Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00211939 · ClinicalTrials.gov registry record · Phase 4

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

A Phase 4 study of Arteriosclerosis and Calcinosis, sponsored by Nabi Biopharmaceuticals.

Completed
Registry status
Phase 4
Development phase
203
Enrollment target
1
Study location

NCT00211939 is a Phase 4 study of Arteriosclerosis and Calcinosis that has completed, run by Nabi Biopharmaceuticals. The registered enrollment target is 203 participants, below the 3,120-participant average among 5 other Arteriosclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00211939, a Phase 4 study of Arteriosclerosis and Calcinosis, has completed, sponsored by Nabi Biopharmaceuticals.

COMPLETED
Registry status
Phase 4
Development phase
203 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate the effects of two phosphate binders, PhosLo and sevelamer, on heart calcification in dialysis patients. The study will use a non-invasive technique, electron beam computed tomography (CT) scanning, to measure calcium in the coronary arteries, the aortic valve, and the mitral valve.

Conditions Studied

Arteriosclerosis Calcinosis Hyperparathyroidism, Secondary

Interventions

  • DRUG atorvastatin
  • DRUG calcium acetate
  • DRUG sevelamer

Study Locations (1)

Texas

  • University of Texas Health Sciences Center - San Antonio

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2005-01
Est. Completion 2007-03
Phase Phase 4

Sponsor

Nabi Biopharmaceuticals

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00211939

The ClinicalTrials.gov registry entry for NCT00211939 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,120-participant average among 5 other Arteriosclerosis trials with a reported enrollment target (93% lower). The listed sponsor is Nabi Biopharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Arteriosclerosis appearing as the primary indexed condition, and to 3 interventions - of which atorvastatin is the first listed.

NCT00211939 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00211939 about?

NCT00211939 is a clinical study titled "CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients". The purpose of the study is to evaluate the effects of two phosphate binders, PhosLo and sevelamer, on heart calcification in dialysis patients. The study will use a non-invasive technique, electron beam computed tomography (CT) scanning, to measure calcium in the coronary arteries, the aortic valve...

What is the current status of trial NCT00211939?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 203 participants. The study started on 2005-01. Estimated completion is 2007-03.

What conditions does trial NCT00211939 study?

This clinical trial studies the following conditions: Arteriosclerosis, Calcinosis, Hyperparathyroidism, Secondary.

What interventions are being tested in trial NCT00211939?

The interventions under investigation include: atorvastatin (DRUG), calcium acetate (DRUG), sevelamer (DRUG).

Who is sponsoring clinical trial NCT00211939?

This trial is sponsored by Nabi Biopharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00211939 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arteriosclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arteriosclerosis

All registered trials for this condition

Calcinosis

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.